Hepatocellular carcinoma pathogenesis: Does PPAR alpha polymorphism have a role in hepatocarcinogenesis associated with HBV and HCV infections?

References (17)

1. Block TM, Mehta AS, Fimmel CJ, et al. Molecular viral oncology of hepatocellular carcinoma. Oncogene 2003;22:5093-107
2. Lotz G, Kiss A, Novak PK, et al. Hepatitis viruses and hepatocarcinogenesis. J Physiol Paris 2001;95:417–22
3. Buendia MA. Genetics of hepatocellular carcinoma. Semin Cancer Biol 2000;10:185–200
4. Berchot C, Gözüaç›k D, Murakami Y, et al. Molecular bases for the development of hepatitis B virus (HBV)–related hepatocellular carcinoma (HCC). Semin Cancer Biol 2000;10: 211–31
5. Koike K. Hepatitis C virus contributes to hepatocarcinogenesis by modulating metabolic and intracellular signaling pathways. J Gastroenterol Hepatol 2007;22:108–11
6. Gronbaek K, Hother C, Jones PA. Epigenetic changes in cancer. APMIS 2007;115:1039–59
7. Baylin SB, Ohm JE. Epigenetic gene silencing in cancer – a mechanism for early oncogenic pathway addiction. Nat Rev Cancer 2006;6:107–15
8. Wiemann SU, Satyanarayana A, Tsahuridu M, et al. Hepatocyte telomere shortening and senescence are general markers of human liver cirrhosis. FASEB J 2002;16:935–42. 9. d’Adda di Fagagna F, Reaper PM, Clay–Farrace L, et al. A DNA damage check point response in telomere–initiated senescence. Nature 2003;426:194–8
9. Artanti SE, Chang S, Lee SL, et al. Telomere dysfunction promotes non–reciprocal translocations and epithelial cancers in mice. Nature 2000;406:641–5
10. Pelentz RR, Caselitz M, Bleck JS, et al. Hepatocellular telomere shortening correlates with chromosomal instability and the development of human hepatoma. Hepatology 2004;40:80–6
11. Plentz RR, Park YN, Lechel A, et al. Telomere shortening and inactivation of cell cycle checkpoints characterize human hepatocarcinogenesis. Hepatology 2007;45:968–76
12. Huang H, Fuji H, Sankila A, et al. Beta–catenin mutations are frequent in human hepatocellular carcinomas associated with hepatitis C virus infection. Am J Pathol 1999;155: 1795–801
13. El–Serag H, Rudolph LK. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology 2007;132:2557–76
14. Wright WE, Shay JW. The two stage mechanism controlling cellular senescence and immortalization. Ex Gerontol 1992;27:383–9
15. Farazi PA, DePinto RA. Hepatocellular carcinoma pathogenesis: from genes to environment. Nature 2006;6:674–86
16. Michalic L, Desvergne B, Wahli W. Peroxisome–proliferators- activated receptors and cancers: complex stories. Nature 2004;4:61–70
17. Borbath I, Horsmans Y. The role of PPAR gamma in hepatocellular carc